Sertraline in stroke-associated lability of mood

Completed

Phase N/A Results

Summary of Purpose

To assess whether a selective serotonin reuptake inhibitor is effective in the treatment of stroke-associated lability of mood.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 September 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Pfizer

Trial Design

Double-blind, randomized, placebo-controlled, parallel group trial of 28 patients at 3 centers.

Contacts

  • Alistair Burns, Department of Old Age Psychiatry, Withington Hospital, West Didsbury, Manchester M20 8LR, UK.

    A_Burns@fs1.with.man.ac.uk